Upgrade to SI Premium - Free Trial

Form EFFECT Cadrenal Therapeutics,

April 30, 2026 6:16 AM
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: April 29, 2026 5:00 P.M.
Form: S-3
CIK: 0001937993
Company Name: Cadrenal Therapeutics, Inc.
File Number: 333-295200

Categories

SEC Filings